Postsynaptic density 95 (PSD-95) is an important regulator of synaptic structure and plasticity. However, its contribution to synapse formation and organization remains unclear. Using a combined electron microscopic, genetic, and pharmacological approach, we uncover a new mechanism through which PSD-95 regulates synaptogenesis. We find that PSD-95 overexpression affected spine morphology but also promoted the formation of multiinnervated spines (MISs) contacted by up to seven presynaptic terminals. The formation of multiple contacts was specifically prevented by deletion of the PDZ2 domain of PSD-95, which interacts with nitric oxide (NO) synthase (NOS). Similarly, PSD-95 overexpression combined with small interfering RNA–mediated down-regulation or the pharmacological blockade of NOS prevented axon differentiation into varicosities and multisynapse formation. Conversely, treatment of hippocampal slices with an NO donor or cyclic guanosine monophosphate analogue induced MISs. NOS blockade also reduced spine and synapse density in developing hippocampal cultures. These results indicate that the postsynaptic site, through an NOS–PSD-95 interaction and NO signaling, promotes synapse formation with nearby axons.
Postsynaptic scaffolding proteins of the membrane-associated guanylate kinase family, which includes such members as postsynaptic density 95 (PSD-95), SAP-97, or SAP102, play major roles in synapse organization and function (Funke et al., 2005). Among these proteins, PSD-95 has been particularly studied because in the central nervous system it is one of the major constituents of excitatory PSDs (Chen et al., 2005), and it is directly involved in synaptic plasticity (Migaud et al., 1998). Overexpression of PSD-95 in neurons is associated with modifications in the properties of synaptic transmission, which mimic and occlude long-term potentiation (LTP; Stein et al., 2003). This effect appears to be related to a role of PSD-95 in the synaptic targeting of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (Chen et al., 2000; Schnell et al., 2002) and in their regulated expression during plasticity (Ehrlich and Malinow, 2004). For this, PSD-95 interacts with the AMPA receptor–associated protein stargazin (Schnell et al., 2002) and regulates not only the surface expression of AMPA receptors but also their diffusion and trapping at synaptic sites (Bats et al., 2007).
In addition to synaptic function, PSD-95 has also been proposed to affect synapse maturation and stabilization (El-Husseini et al., 2000; Ehrlich et al., 2007; De Roo et al., 2008) and, thus, synapse number. Acute knockdown of PSD-95 reduces the development of synaptic structures (Ehrlich et al., 2007), and PSD-95 mutant mice exhibit variations in spine densities in several brain regions (Vickers et al., 2006). However, these mechanisms remain essentially unexplained but could depend on several interesting properties of the protein. PSD-95 shows a continuous dynamic regulation between intracellular and synaptic pools (Bresler et al., 2001; Gray et al., 2006) and also interacts with several important synaptic proteins, including synaptic GTPase-activating protein, neuroligins, or nitric oxide (NO) synthase (NOS), which might mediate trans-synaptic signaling (Kim and Sheng, 2004) for synapse formation or stabilization.
To examine these issues, we used a quantitative electron microscopic analysis of serially sectioned dendritic segments of CA1 neurons in hippocampal slice cultures and found that overexpression of PSD-95 not only affected the morphological characteristics of dendritic spines but also resulted in the formation of spines contacted by several different presynaptic partners. Through genetic and pharmacological manipulations, we provide evidence that this effect depends on an interaction between PSD-95 and NOS and requires NO signaling. Together, these data identify a novel mechanism through which expression of PSD-95 promotes synapse formation with nearby axons, a result that strongly emphasizes the importance of the postsynaptic element in driving contact formation during synaptogenesis.
Ultrastructural analyses of PSD-95–transfected pyramidal neurons
To examine the effect of PSD-95 overexpression on spine morphology, we transfected hippocampal organotypic slice cultures with a PSD-95 tagged with EGFP using a biolistic approach. 2 d after transfection, neurons showed the classical punctuate PSD-95 staining of synapses (Fig. 1, A and B). The tissue was then processed for EM analyses using anti-EGFP antibodies to reveal the transfected neurons and their dendritic spines (Fig. 1, C and D). Through serial sectioning and 3D reconstruction of labeled dendritic segments (Fig. 1 E), we examined the ultrastructural characteristics and distribution of synapses. As controls, we analyzed EGFP-transfected neurons and also nontransfected neurons located close to the PSD-95– or EGFP-transfected cells (Fig. 1 F). In total, 1,314 spine synapses from 72 different cells obtained under 12 different conditions were three-dimensionally reconstructed in this study (Table S1, available at http://www.jcb.org/cgi/content/full/jcb.200805132/DC1).
As shown in Fig. 2, PSD-95 overexpression modified the ultrastructural features of dendritic spines and PSDs. Analysis of 234 spines from PSD-95–transfected neurons (n = 7 cells), 164 spines from EGFP-transfected cells (n = 4 cells), and 145 spines from nontransfected neurons (n = 8 cells) showed that spines in PSD-95–transfected cells become much larger, often with complex shapes and membrane extensions that engulf presynaptic terminals. The spine volume increased by factors of 2.3 and 2.8 when compared with either EGFP neurons (0.144 ± 0.023 μm3 vs. 0.064 ± 0.011 μm3) or nontransfected neurons (0.051 ± 0.006 μm3; P < 0.05; Fig. 2 C). The increase of the PSD area was even more pronounced (5.7× and 8.2× the mean value of EGFP and control neurons; 0.189 ± 0.043 μm2 vs. 0.033 ± 0.004 μm2 and 0.023 ± 0.002 μm2, respectively; P < 0.05; Fig. 2 D). The proportion of spines with complex PSDs, characterized by a discontinuity on a single section, was also significantly increased in comparison with control cells (46.6 ± 5% vs. 8.5 ± 1% or 5.7 ± 1.4%; P < 0.05; Fig. 2 E). In addition, PSD-95 overexpression resulted in a decrease in spine density as indicated by analysis of the three-dimensionally reconstructed segments (PSD-95, 0.63 ± 0.12 spines/μm of dendritic length; EGFP, 0.96 ± 0.29 spines/μm of dendritic length; n = 7 and 4 cells, respectively; P < 0.05; Table S1), a result also confirmed by analyzing the number of fluorescent puncta observed on transfected cell dendrites (PSD-95–transfected cells, 0.74 ± 0.03 puncta/μm; spines on EGFP-transfected cells, 0.94 ± 0.9 puncta/μm; n = 14 and 8 cells, respectively; P < 0.05).
Multiinnervated spines (MISs) in PSD-95–transfected cells
EM analysis of PSD-95–transfected neurons revealed the presence of numerous MISs characterized by several presynaptic terminals contacting the same postsynaptic spine through independent PSDs (Fig. 3, A, B, and D; Fig. S1, and Videos 1 and 2, available at http://www.jcb.org/cgi/content/full/jcb.200805132/DC1). MISs contacted by two terminals can be observed in the hippocampus in vivo and in vitro and account for a small fraction of all spines, although during the early postnatal development, dendritic protrusions exhibiting multiple synaptic contacts are rather prominent (Fiala et al., 1998). PSD-95 transfection resulted in a significant increase in the number of MISs (mean number: EGFP control, 2.0 ± 1.3%; nontransfected, 1.8 ± 1.1%; PSD-95, 29.1 ± 2.9%; P < 0.01; Fig. 3 C) and in their complexity. On some dendritic segments, their occurrence increased markedly, as illustrated in Fig. 3 E in which 16 out of 28 spines exhibited synaptic contacts with multiple presynaptic terminals. The increased complexity of these structures is indicated by the number of presynaptic terminals making contact with a single spine (Fig. 3 E). This number varied between two and seven in PSD-95–transfected cells, whereas the maximum observed under control conditions was only two (see Fig. S2 for a distribution of the number of contacts). Furthermore, in the case of MISs, the individual PSDs could show a complex organization with perforated or segmented PSDs in the synaptic contacts made by several axons on the same spine (Videos 1 and 2). A final characteristic of MISs is their unusually large size (0.29 ± 0.028 μm3 compared with 0.064 ± 0.011 μm3 in EGFP-transfected cells) and the fact that they exhibit large PSD areas both at individual contacts (0.164 ± 0.012 μm2 compared with 0.033 ± 0.004 μm2 in EGFP-transfected cells; n = 190 and 175 PSDs, respectively; P < 0.01) and on the entire spine (sum of all PSDs on a given spine, 0.466 ± 0.047 μm2; n = 68 MISs; Fig. 3 F).
Role of PSD-95 in MIS formation
To understand how PSD-95 overexpression could induce multiple axons to form synapses on a given spine, we examined which region of the protein could be involved in these effects. Numerous interactions of PSD-95 occur through its PDZ domains that typically bind PDZ domains or specific carboxy-terminal sequences in target proteins. We started by generating PSD-95 mutants with deletions in the PDZ2 and PDZ3 regions. PDZ2 binds synaptic GTPase-activating protein, an adhesion molecule implicated in the regulation of synapse formation (Kim et al., 1998; Vazquez et al., 2004), and neuronal NOS (nNOS), the source of a possible trans-synaptic messenger (Tochio et al., 2000; Sunico et al., 2005), whereas the PDZ3 domain is involved in interactions with neuroligin, another adhesion molecule implicated in synapse formation mechanisms (Prange et al., 2004; Gerrow et al., 2006). These mutant PSD-95–EGFP constructs were then transfected in pyramidal neurons, and the cells were processed for EM analyses.
Fig. 4 (A and B) shows three-dimensionally reconstructed dendritic segments from cells transfected with each of those constructs. Interestingly, expression of PDZ3 mutant PSD-95 in neurons still resulted in numerous MISs (Fig. 4, A and C). Their proportion did not change, nor did the mean spine volume or PSD area of three-dimensionally reconstructed spines as compared with PSD-95–transfected neurons (MISs, 22.1 ± 4.5% vs. 29.1 ± 2.9%; spine volume, 0.168 ± 0.012 μm3 vs. 0.144 ± 0.023 μm3; PSD area, 0.169 ± 0.03 μm2 vs. 0.189 ± 0.043 μm2; n = 3 and 7 cells for PDZ3 mutant and PSD-95–transfected cells, respectively; Fig. 4, C–E). In contrast, the number of MISs markedly decreased in cells expressing the PDZ2 mutant PSD-95 (PDZ2 mutant, 1.7 ± 1.7% vs. PSD-95, 29.1 ± 2.9%; n = 3 and 7 cells, respectively; P < 0.01; Fig. 4, B and C), reaching values similar to those found in control cells (neighboring, nontransfected neurons, 2.0 ± 1.3%; n = 8 cells). The mean spine volume, however, remained significantly enlarged compared with control cells (0.131 ± 0.021 μm3; P < 0.05) as well as the mean PSD area (0.094 ± 0.019 μm2; P < 0.05; Fig. 4, D and E). Thus, expression of a PDZ2 mutant PSD-95 resulted in the enlargement of spines with increased PSD areas but specifically prevented formation of multiinnervated structures.
Role of NOS in MIS formation
As the PDZ2 domain of PSD-95 is involved in interactions with different partners and because we previously found that NO could affect axonal varicosity remodeling (Nikonenko et al., 2003), we tested the role of nNOS and NO in the formation of MISs. For this, we performed two groups of experiments to examine whether suppression of NOS activity in cells overexpressing PSD-95 prevented the formation of MISs. First, we used an NOS siRNA, which markedly inhibited nNOS expression in fibroblasts (Fig. S3, available at http://www.jcb.org/cgi/content/full/jcb.200805132/DC1) and also interfered with NOS expression at synapses (see Fig. 6). Second, we transfected pyramidal neurons with PSD-95–EGFP and treated the slice cultures for 2 d after transfection with 200 μM of the NOS inhibitor l-NG-nitroarginine methyl ester (L-NAME) in the culture medium. This treatment did not induce any toxicity, as indicated by propidium iodide staining (unpublished data). Slice cultures were then processed for EM analyses. As illustrated in Fig. 5, both down-regulation of NOS by the siRNA approach and treatment of slice cultures with the NOS inhibitor prevented the formation of MISs. The decrease was partial but significant with nNOS siRNA transfection (7.8 ± 5.1%; n = 5 cells), whereas the blockade of MIS formation was complete with L-NAME treatment of PSD-95–transfected neurons (4.4 ± 1.9%, n = 4 cells vs. 2.0 ± 1.3%, n = 8 cells for control; 29.1 ± 2.9%, n = 7 cells for PSD-95; Fig. 5 C). Interestingly, the increase in spine volume and PSD area associated with PSD-95 overexpression was not blocked by these manipulations (spine volume, 0.131 ± 0.012 μm3 and 0.125 ± 0.025 μm3; PSD area, 0.129 ± 0.014 μm2 and 0.118 ± 0.016 μm2 for siNOS [silencing RNA for NOS] and L-NAME, respectively; Fig. 5, D and E).
Interaction between PSD-95 and nNOS expression
If PSD-95 regulates MIS formation through its interaction with nNOS, one would expect that modifications of PSD-95 expression should affect nNOS expression. To investigate this possibility and the level of expression of these two proteins, we compared by immunohistochemistry the size of PSD-95– and nNOS-immunostained puncta and their colocalization under four experimental conditions: control situation, PSD-95 overexpression, expression of the PDZ2 mutant of PSD-95, and, finally, overexpression of PSD-95 together with nNOS siRNA. Fig. 6 illustrates PSD-95– and nNOS-immunostained PSD spots as visualized by confocal microscopy in the CA1 stratum radiatum. Under control conditions, small nNOS puncta (Fig. 6 A, red), which are usually smaller than PSD-95–labeled puncta (Fig. 6 A, blue), are seen everywhere in the dendritic region. They often colocalize with PSD-95 staining (Fig. 6 A, right), confirming the presence of nNOS at excitatory synapses. However, not all PSD-95–stained puncta express a detectable amount of nNOS, and there are nNOS puncta that do not colocalize with PSDs. In areas containing cell dendrites of PSD-95–EGFP-transfected neurons (Fig. 6 B, green PSD spots), PSD-95 immunostaining (Fig. 6 B, blue PSD spots) perfectly reveals the same PSD spots as EGFP together with a few other spots on neighboring cells. Comparisons of the size of PSD-95–immunostained puncta on PSD-95–transfected and nontransfected cells shows a 5.4× increase in the size of PSD spots, a result that reflects the increased level of expression of PSD-95 in transfected cells (n = 4 PSD-95–transfected cells; 95 and 105 puncta analyzed; P < 0.01; Fig. S4, available at http://www.jcb.org/cgi/content/full/jcb.200805132/DC1). Note that in all other conditions of transfection analyzed in this study (PDZ2, PDZ3, and PSD-95 + siNOS), the increase in size of PSD-95–immunostained puncta is comparable, suggesting a similar level of expression of the different constructs used (Fig. S4). Most importantly, however, immunostaining reveals that the size of nNOS puncta in PSD-95–transfected cells is also markedly larger (factor of 6.4; n = 4 cells; P < 0.05; Fig. 6 E), indicating that PSD-95 overexpression is indeed associated with a concomitant increase of nNOS expression at the same synapse. As a result, the level of colocalization between PSD-95 and nNOS immunostaining also markedly increased (n = 4; P < 0.05; Fig. 6 F). In contrast, in cells transfected with the PDZ2 mutant of PSD-95 or with PSD-95 + siNOS, the enlargement of PSD-95 puncta is not associated with a similar change of nNOS puncta; they remain small (Fig. 6, C–E), and the level of colocalization of nNOS and PSD-95 immunostaining is essentially unchanged (Fig. 6 F), confirming the role of PSD-95 in regulating the level of nNOS expression at excitatory synapses.
Role of NO in MIS formation
If NO is indeed responsible for MIS formation, their frequency should increase by exogenous application of NO or by activating signaling cascades associated with NO such as cyclic guanosine monophosphate (cGMP) formation. To test this, we incubated slice cultures for 2 d with 150 μM of the NO donor diethylenetriamine (DETA) NONOate or with the cell-permeable cGMP analogue 8-Br-cGMP (8-bromo-cGMP sodium salt). As illustrated in the EM pictures and 3D reconstructions of Fig. 7 A, these two conditions resulted in MIS formation in the entire tissue. Using serial sections and 3D reconstructions, we analyzed 2,161 spines in randomly chosen volumes in stratum radiatum taken from nine different slice cultures and determined the proportion of MISs. This proportion increased from 2.5 ± 0.3% under control condition to 23.7 ± 4.7% after DETA NONOate treatment and, thus, is very close to the values obtained in PSD-95–transfected cells (n = 3 cultures for each condition; 615 and 583 spines analyzed; P < 0.01; Fig. 7 C). Furthermore, DETA NONOate treatment increased MISs not only on all cells of treated cultures but also on cells overexpressing the PDZ2 mutant of PSD-95 (32.9 ± 8.6% of MISs; n = 4; P < 0.05; Table S1), indicating that the effect of NO is indeed downstream of PSD-95. Similarly, the application of 5 mM 8-Br-cGMP increased the proportion of MISs in the entire tissue to 12.0 ± 1.8% (n = 3 cultures; 963 spines analyzed; P < 0.01). Conversely, the blockade of cGMP by 25 μM of the inhibitor ODQ (1H-[1,2,4]oxadiazole[4,3-α]quinoxalin-1-one) prevented formation of MISs on PSD-95–transfected neurons (7.2 ± 0.5%; n = 3; Table S1). Interestingly, although both the NO donor and cGMP analogue promoted MIS formation, the PSDs expressed on these MISs did not differ in size from those measured under control conditions (Fig. 7 D). Thus, NO production is sufficient for the generation of MISs and does not require overexpression of PSD-95.
Mechanism of NO-mediated MIS formation
We then investigated whether NO promoted multiple contact formation by attracting axons toward PSD-95–overexpressing spines or whether it rather favored axonal varicosity differentiation and synaptic contact formation with axons already present in the vicinity of the spine. For this, we analyzed the number of axons in contact with 12 reconstructed MISs from PSD-95–transfected cells and 12 spines from cells overexpressing PSD-95 that were treated with L-NAME. Reconstructed spines were selected so as to exhibit exactly the same size (Fig. 8, A–C). However, the mean number of synapses established with each spine was much higher in PSD-95–transfected cells (3.33 ± 0.32 vs. 1.17 ± 0.17 in PSD-95– and L-NAME–treated cells, respectively; P < 0.05; Fig. 8 E). Interestingly, the number of axons found in close proximity to the spine membrane was actually similar (7.8 ± 0.3 for PSD-95 vs. 7.6 ± 0.5 for L-NAME; Fig. 8 D). However, these axons mainly exhibited features of differentiated terminals in the case of PSD-95–transfected cells (enlargement and presence of vesicles, including docked vesicles; 4.7 ± 0.2 axonal varicosities and 3.1 ± 0.2 axonal shafts), whereas they mainly corresponded to axonal shafts in the case of L-NAME treatment (2 ± 0.3 varicosities and 5.6 ± 0.4 axonal shafts; P < 0.05; Fig. 8 F). Therefore, the main effect of NO was to promote presynaptic terminal differentiation and formation of a synaptic contact by the axons already present in the direct vicinity of the spine.
Physiological role of NO in spine synapse formation
We then asked whether NO also contributed to synapse formation under control conditions. For this, we examined the morphology and density of spines in slice cultures treated for 2 d with the NOS inhibitor L-NAME. This condition clearly affected the mechanisms of spine and synapse formation as both the density of spines and of synapses considerably decreased upon L-NAME treatment (0.65 ± 0.11 spines/μm vs. 1.08 ± 0.12 spines/μm and 0.72 ± 0.12 synapses/μm vs. 1.2 ± 0.12 synapses/μm; n = 8 cells; P < 0.05; Fig. 9, A and B; and Table S1). However, the morphology of remaining spines was not affected, as both the spine volume and PSD area were only slightly different from the values obtained in control tissue (0.078 ± 0.016 μm3 and 0.042 ± 0.008 μm2), and the number of MISs was also very low (1.7 ± 1.7%). Thus, synapse formation under control conditions also appears to require NO signaling to be effective.
This study examined the morphological properties of excitatory synapses upon overexpression of PSD-95 and reveals important new functions of this protein in regulating spine synapse formation and plasticity. The expression of PSD-95 resulted in changes in spine shape, a marked increase of the spine volume, and an enlargement of the PSD, resulting in the formation of synapses with complex and perforated or segmented PSDs. The effect is very significant because, on average, the PSD area increased by a factor of six to eight, and the spine volume increased about threefold, emphasizing the close relationship existing between spine volume and PSD size (Harris and Stevens, 1989; Harris et al., 1992). These results are consistent with the notion that PSD-95, as a major scaffold protein, shapes the PSD and regulates the expression of several proteins or receptors that are important for synaptic function and plasticity (Stein et al., 2003; Xu et al., 2008), including NOS (Chen et al., 2000; Ishii et al., 2006). This probably accounts for the general increase in synaptic efficacy and AMPA receptor–mediated currents reported at individual synapses in PSD-95–transfected cells (Stein et al., 2003; Ehrlich and Malinow, 2004). It is also interesting that the changes associated with PSD-95 overexpression share many similarities, both at the functional and morphological level, with those reported after LTP induction. At the functional level, PSD-95 overexpression mimics and occludes LTP (Stein et al., 2003; Ehrlich and Malinow, 2004), whereas at the morphological level, the two situations seem to involve an enlargement of the spine and the formation of spines with complex, perforated PSDs (Geinisman, 1993; Buchs and Muller, 1996; Matsuzaki et al., 2004). One possibility with regard to these changes in spine volume and efficiency is that they promote spine stability (Kasai et al., 2003).
The most intriguing finding of this study, however, is the observation that overexpression of PSD-95 results in the formation of MISs. Although dendritic spines connected by two distinct presynaptic terminals can occasionally be found in the hippocampus, their number is usually low, in the range of a few percentages (Fiala et al., 1998; Nikonenko et al., 2003). However, MISs are regulated under various conditions involving enhanced synaptogenesis such as the blockade of synaptic transmission (Petrak et al., 2005) or induction of plasticity (Nikonenko et al., 2003). There is also one study suggesting the existence of MISs in a hibernating mammal (Popov et al., 2005). In this study, we found that overexpression of PSD-95 increased their occurrence by a factor of 10 as well as their complexity because MISs contacted by three to seven different axon terminals were frequently observed. It is interesting that these conditions of enhanced spine innervation and synaptic efficacy were actually associated with a reduction of spine density. The mechanisms remain unclear but could involve a kind of homeostatic process through which activity may regulate the number of synapses.
The importance of these findings resides in the new understanding of the role of PSD-95 and of its interaction with nNOS for mechanisms of synaptogenesis and their regulation of presynaptic differentiation and contact formation. Our results demonstrate that PSD-95 controls synapse formation through its regulation of nNOS expression at the synapse, the release of NO, and most likely the activation of cGMP signaling in presynaptic axons. This conclusion is supported by several observations: (a) PSD-95 overexpression is associated with an increased expression of nNOS in PSDs and the formation of MISs; (b) deletion of the PDZ2 domain of PSD-95 specifically prevented the increased expression of nNOS and the formation of MISs; (c) overexpression of PSD-95 together with siRNA down-regulation of nNOS also markedly reduced nNOS expression at the synapse and prevented formation of MISs; (d) the pharmacological blockade of nNOS prevented MIS formation; and, conversely, (e) the exogenous application of the NO donor DETA NONOate or enhancement of cGMP signaling, a classical downstream target of NO, reproduced MIS formation in the entire slice culture and without alterations of PSD size. Also, DETA NONOate treatment was able to rescue the absence of MISs in PDZ2-transfected cells, and, finally, the pharmacological blockade of nNOS interfered with spine and synapse development under control conditions. Thus, PSD-95 and nNOS are key regulators of the mechanisms of synapse formation.
This conclusion is consistent with and could account for the defects in synapse development reported upon suppression of PSD-95 (Ehrlich et al., 2007). This is also in line with the variations in spine density found in various brain areas in PSD-95 knockout mice (Vickers et al., 2006), although some compensatory mechanisms could probably be involved. Most importantly, however, these results may help to understand the function of PSD-95 in the stabilization of new synapses. During development, spine turnover in cortical structures is rather high (Holtmaat et al., 2005; Zuo et al., 2005; De Roo et al., 2008), and recent evidence indicates that newly formed spines do initially grow without a PSD and possibly without a presynaptic partner (Knott et al., 2006; Arellano et al., 2007; De Roo et al., 2008). PSDs, and particularly PSD-95, start to be expressed after a few hours, a step that is critical for the stabilization of the newly formed spine (Marrs et al., 2001; Prange and Murphy, 2001; De Roo et al., 2008). Our current results suggest a scenario in which PSD-95 expression at a new protrusion, through association with nNOS and NO production, would stimulate the differentiation of a close-by axon into a presynaptic varicosity and the establishment of a morphologically mature synapse. NO release would therefore represent a signal informing axons in the vicinity of the existence of a potential postsynaptic partner, and absence of NO or failure of axons to respond could then result in elimination of the protrusion.
Upon overexpression of PSD-95, this mechanism is overemphasized, and more axons located around the spine become stimulated by NO, start to differentiate into varicosities, and then form MISs, an effect that could be mediated by activation of cGMP signaling in presynaptic structures. Alternatively, the excess of NO release could represent a local neurotoxic situation to which axons respond by increasing synaptogenesis. Although difficult to exclude, this possibility seems unlikely because MISs are formed exclusively with PSD-95–overexpressing spines and not with other spines in the area, indicating specificity. Furthermore, the role of PSD-95 and NO uncovered in this study is likely to be physiologically relevant for different reasons. First, it certainly operates under control conditions for the formation of synapses involving a single presynaptic partner because, as shown in this study, the acute blockade of nNOS resulted in a marked reduction in the density of dendritic spines and of synapse formation. Second, these mechanisms can also account for the formation of MISs both in control brain tissue and under conditions in which MISs are increased, such as after the blockade of synaptic transmission (Petrak et al., 2005) or induction of synaptic plasticity (Nikonenko et al., 2003). A role for NO in these mechanisms would actually be in line with previous work showing that the application of an NO donor to hippocampal slice cultures results in an increased dynamic and growth of presynaptic varicosities (Nikonenko et al., 2003). Third, this mechanism could also account for the observation that newly formed spines in adult tissue or on newly generated neurons very often target existing terminals (Knott et al., 2006; Toni et al., 2007), providing a means through which newly formed dendritic protrusions can enter into competition with preexisting synaptic contacts. The role of PSD-95 in regulating these mechanisms might therefore be instrumental for the stabilization and pruning of synaptic networks and emphasizes the critical role played by the postsynaptic structure in driving the selection of the presynaptic partner. Finally, these mechanisms might also be implicated in some neuropathological aspects because multiinnervated giant spines have been reported along Purkinje cells during malnutrition or in the cortical tissue surrounding tumors (Chen and Hillman, 1980; Fiala et al., 2002). Excessive expression of PSD-95 or nNOS under these conditions could account for these abnormalities. In conclusion, the molecular regulation between PSD-95 and nNOS uncovered in this study provides a new mechanism through which postsynaptic structures can promote synapse formation.
Materials And Methods
Slice cultures, constructs, and siRNAs
Organotypic hippocampal slice cultures were prepared from 7-d-old rat pups as previously described (Stoppini et al., 1991), and all experiments were performed with slice cultures maintained 11–15 d in vitro (DIV).
The PSD-95–EGFP fusion construct prepared in the GW1 mammalian expression vector was a gift from D.S. Bredt (University of California, San Francisco, San Francisco, CA). The vectors PSD-95–EGFP-PDZ2 and PSD-95–EGFP-PDZ3 were produced using the same strategy. The plasmids produced after ligation and transformation have been verified by enzyme restriction, sequencing, and Western blot analyses through fibroblast cell line transfection. siRNAs were obtained from QIAGEN (HiPerformance GenomeWide duplexes). The target sequence for rat nNOS was 5′-CAGGAGATGCTCAACTATAGA-3′. As a control, we used the AllStar Negative Control siRNA, which has no sequence homology in the mammalian genome.
Transfections and immunoblots
Mouse NIH 3T3 fibroblasts, which do not express endogenous nNOS, were transfected with rat nNOS by Lipofectamine 2000 (Invitrogen) or cotransfected with nNOS and either the siRNA against nNOS or the nonsilencing siRNA. 48 h after transfection, the fibroblasts were harvested, and total protein was extracted. 30 μg of proteins was separated by SDS-PAGE (NuPAGE; Invitrogen), transferred to nitrocellulose membrane, and incubated with 1:1,000 anti-nNOS rabbit polyclonal antibody (Millipore) and 1:10,000 anti–β-actin mouse antibody (Sigma-Aldrich) followed by anti–mouse and anti–rabbit IgG HRP conjugates (Bio-Rad Laboratories) before detection using ECL (GE Healthcare).
Organotypic hippocampal cultures were transfected or cotransfected at 11 DIV with the different constructs using the hand-held Gene Gun biolistic technique (DNA-coated gold microcarriers; 1.6 μm; Bio-Rad Laboratories) according to the instructions of the manufacturer. Usually, one out of four transfected slice cultures (with 1–10 transfected pyramidal cells per slice) showed efficient transfection of pyramidal cells. The transfection of other cell types could also occur, but less reliably. Only one transfected CA1 pyramidal cell per slice was analyzed in this study. Transfected cells were used for morphological experiments 2 d after transfection.
To reveal PSD-95 and nNOS molecules, we applied a proteolytic treatment known to unmask hidden antigenic epitopes (modified from Burette et al., 2002). Immunostaining was performed using the following antibodies: 1:8,000 primary anti-nNOS rabbit polyclonal antibody (Millipore) applied overnight at 4°C followed by 1:1,000 secondary anti–rabbit antibodies (Alexa Fluor 555; Invitrogen) applied for 2 h at room temperature and 1:20,000 primary anti–PSD-95 mouse monoclonal antibody (Thermo Fisher Scientific) applied overnight at 4°C followed by 1:1,000 secondary anti–mouse antibodies (Alexa Fluor 647; Invitrogen) applied for 2 h at room temperature. The images were taken with a confocal microscope (LSM 510; Ar laser 458/488/514 nm, 25 mW; HeNe 543 nm, 1 mW; HeNe 633 nm, 5 mW; Carl Zeiss, Inc.) using a Plan-Apochromat 63× NA 1.4 oil objective. Colocalization was analyzed using ImageJ software (National Institutes of Health) and the colocalization plug-in with the same default threshold parameters for all images analyzed. Colocalization was then quantified for fields of the same size (512 × 512 pixels; 30 × 30 μm) on a single confocal plane by calculating the number of pixels positive for two different stains. We verified that a shift of 15 pixels in the xy plane reduced the level of colocalization by a factor of three and prevented the increase detected in PSD-95–expressing cells.
After the imaging of transfected cells in a confocal spinning-disk microscope (Visitron Systems) with MetaMorph software (Visitron Systems), the slice cultures were fixed with 2% paraformaldehyde and 0.2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, cryoprotected, freeze thawed in liquid nitrogen, and incubated overnight in 1:500 primary rabbit anti-GFP antibody (Millipore) at 4°C and then in 1:200 biotinylated secondary goat anti–rabbit antibody (Jackson ImmunoResearch Laboratories) and avidin biotin peroxidase complex (Vector Laboratories) followed by 3,3′-diaminobenzidine tetrachloride and 0.015% hydrogen peroxide. After embedding in EPON resin (Fluka), the cultures were trimmed for cutting around labeled cells of interest, and 60-nm serial ultrathin sections were cut. Images of labeled dendrites from the middle portion of CA1 stratum radiatum were taken at a magnification of 9,700–15,000 using transmission electron microscopes (Philips CM10, Philips CM12, and Tecnai G212; FEI Company) equipped with digital cameras (Mega View III and Morada; Soft Imaging Systems). Synapses were defined by the presence of a PSD facing at least two to three presynaptic vesicles. Complex or perforated PSDs were defined by the presence of a discontinuity on a single section. Terminals were identified by the presence of an enlargement of the axonal shaft containing vesicles and facing at least one PSD.
Digital serial electron micrographs were aligned using Photoshop software (Adobe). 3D reconstructions as well as surface, volume, and length measurements were performed using Neurolucida software (version 6.02; MicroBrightField, Inc.). 3D illustrations were made using the software Reconstruct developed by J.C. Fiala and K.M. Harris (SynapseWeb: http://synapses.clm.utexas.edu/tools/index.stm; Fiala, 2005) followed by color rendering with 3D Studio Max (Discreet Software).
In some experiments, slice cultures (10–11 DIV) were treated for 2 d with either 200 μM of the NOS inhibitor L-NAME, the NO donor DETA NONOate (20-h half-life in solution, 150 μM in culture medium; Enzo Biochem, Inc.), or the cell-permeable 8-Br-cGMP (5 mM in culture medium; Enzo Biochem, Inc.). The drugs were added twice at 24-h intervals. Serial thin sections were cut in the middle part of CA1 stratum radiatum, and the proportion of MISs was analyzed in randomly selected volume samples obtained from treated and control tissue, with images taken of at least 40 consecutive sections at a magnification of 9,700–13,500. For each group, three slice cultures from different experiments were used. To analyze spine density in these experiments, 3D reconstructions of spines were performed in the same volume samples on several dendritic segments per culture.
Data are shown as mean ± SEM. Statistical analyses were performed using the Student's t test or Mann-Whitney test when indicated.
Online supplemental material
Fig. S1 shows serial sections of an MIS from a PSD-95–transfected cell. Fig. S2 shows the distribution of the number of presynaptic partners in MISs. Fig. S3 shows siNOS activity in fibroblasts. Fig. S4 shows the level of expression of PSD-95 in transfected neurons. Video 1 shows the 3D reconstruction of an MIS contacted by six different axons. Video 2 shows the 3D reconstruction of two MISs on the same dendritic segment. Table S1 shows the summary of morphometric analyses. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200805132/DC1.
We thank Marlis Moosmayer and Lorena Jourdain for excellent technical support, Fred Pillonel for help with Photoshop alignment, and Rudolf Kraftsik for statistical analyses.
This work was supported by the Swiss National Science Foundation (grants 3100-105721 to D. Muller and 310000-108246 to E. Welker) and the European projects Promemoria and Synscaff (grants to D. Muller).
Abbreviations used in this paper: AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; cGMP, cyclic guanosine monophosphate; DETA, diethylenetriamine; DIV, day in vitro; L-NAME, l-NG-nitroarginine methyl ester; LTP, long-term potentiation; MIS, multiinnervated spine; nNOS, neuronal NOS; NO, nitric oxide; NOS, NO synthase; PSD, postsynaptic density.
© 2008 Nikonenko et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
- Submitted: 21 May 2008
- Accepted: 7 November 2008